Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation.

Bleckmann, Annalen; Dierks, Sascha; Schildhaus, Hans-Ulrich; Hellige, Niels; Bacher, Vera; Trümper, Lorenz; Wulf, Gerald (2020). Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation. (In Press). Annals of hematology Springer-Verlag 10.1007/s00277-020-03974-y

[img]
Preview
Text
Treatement.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (744kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Bacher, Vera Ulrike

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0939-5555

Publisher:

Springer-Verlag

Language:

English

Submitter:

Pierrette Durand Lüthi

Date Deposited:

15 Jun 2020 08:37

Last Modified:

15 Jun 2020 08:37

Publisher DOI:

10.1007/s00277-020-03974-y

PubMed ID:

32193631

BORIS DOI:

10.7892/boris.144472

URI:

https://boris.unibe.ch/id/eprint/144472

Actions (login required)

Edit item Edit item
Provide Feedback